Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus
- PMID: 18844597
- PMCID: PMC2630464
- DOI: 10.1586/14760584.7.8.1239
Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus
Abstract
Respiratory syncytial virus (RSV) is the leading cause of severe respiratory disease in infants and is an important source of morbidity and mortality in the elderly and immunocompromised. This review will discuss the humoral and cellular adaptive immune responses to RSV infection and how these responses are shaped in the immature immune system of the infant and the aged environment of the elderly. Furthermore, we will provide an overview of our current understanding of the role the various arms of the adaptive immune response play in mediating the delicate balance between the successful elimination of the virus from the host and the induction of immunopathology. Efficacious immunization against RSV remains a high priority within the field and we will highlight recent advances made in vaccine design.
Similar articles
-
Mucosal vaccines against respiratory syncytial virus.Curr Opin Virol. 2014 Jun;6:78-84. doi: 10.1016/j.coviro.2014.03.009. Epub 2014 Apr 29. Curr Opin Virol. 2014. PMID: 24794644 Free PMC article. Review.
-
Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.J Virol. 2012 Apr;86(8):4505-17. doi: 10.1128/JVI.07091-11. Epub 2012 Feb 1. J Virol. 2012. PMID: 22301139 Free PMC article.
-
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.Immunol Rev. 2011 Jan;239(1):149-66. doi: 10.1111/j.1600-065X.2010.00972.x. Immunol Rev. 2011. PMID: 21198670 Free PMC article. Review.
-
Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model.Hum Vaccin Immunother. 2014;10(3):615-22. doi: 10.4161/hv.27383. Epub 2013 Dec 10. Hum Vaccin Immunother. 2014. PMID: 24326268 Free PMC article.
-
A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease.PLoS One. 2011;6(7):e21823. doi: 10.1371/journal.pone.0021823. Epub 2011 Jul 15. PLoS One. 2011. PMID: 21789184 Free PMC article.
Cited by
-
The infectious march: the complex interaction between microbes and the immune system in asthma.Immunol Allergy Clin North Am. 2010 Nov;30(4):453-80, v. doi: 10.1016/j.iac.2010.09.008. Immunol Allergy Clin North Am. 2010. PMID: 21029932 Free PMC article. Review.
-
Evaluation of dual pathogen recognition receptor agonists as adjuvants for respiratory syncytial virus - virus-like particles for pulmonary delivery.Front Immunol. 2025 Mar 17;16:1561297. doi: 10.3389/fimmu.2025.1561297. eCollection 2025. Front Immunol. 2025. PMID: 40176816 Free PMC article.
-
A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.PLoS One. 2015 Mar 20;10(3):e0119509. doi: 10.1371/journal.pone.0119509. eCollection 2015. PLoS One. 2015. PMID: 25793508 Free PMC article.
-
Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.Microbiol Immunol. 2020 Jan;64(1):33-51. doi: 10.1111/1348-0421.12754. Epub 2019 Nov 18. Microbiol Immunol. 2020. PMID: 31692019 Free PMC article.
-
Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse.PLoS One. 2011;6(9):e25500. doi: 10.1371/journal.pone.0025500. Epub 2011 Sep 29. PLoS One. 2011. PMID: 21980478 Free PMC article.
References
-
- Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology. 2006;344(2):328–339. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical